AbCheck - Partnering
 
   
     
 
         
   
  Why partner with AbCheck?
   
         
   
  AbCheck discovers and optimizes human antibodies for a broad range of medical applications. We are flexible in our approach and committed to meet partners’ demands in terms of deal structures balancing front-end and back-end loaded payment models. Companies and institutions such as Tusk, bluebird bio, Eli Lilly, Daiichi Sankyo and others have already chosen to trust AbCheck’s expertise and capabilities to strengthen their research & development pipelines. With Pierre Fabre and Affimed, AbCheck has entered into multiannual strategic research partnerships. So far, AbCheck’s partnered drug discovery activities have resulted in more than 30 drug discovery programs.
   
   
  Imprint Disclaimer